Liposomes as carriers of antimicrobial drugs
Само за регистроване кориснике
1997
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Liposome are promising drug carrier systems being developed. Their successful use in the treatment of several diseases demonstrates that a solid rationale for clinical development of liposomes as antimicrobial drug carriers can be established. There are a number of potential drug candidates for liposome encapsulation. The involvement of several biotechnology companies has culminated in the design and licensing of formulations for the treatment of certain microbial infections and cancers. Understanding of liposome behavior in the body and of the physicochemical mechanisms involved in the interaction of liposome, drug, and cellular targets is essential for their future applications.
Извор:
Drug Development and Industrial Pharmacy, 1997, 23, 5, 483-488Издавач:
- Taylor & Francis Ltd, Abingdon
DOI: 10.3109/03639049709148497
ISSN: 0363-9045
WoS: A1997WV90500006
Scopus: 2-s2.0-0030900491
Институција/група
Tehnološko-metalurški fakultetTY - JOUR AU - Šiler-Marinković, Slavica AU - Mojović, Ljiljana AU - Davinić, V AU - Bugarski, Branko PY - 1997 UR - http://TechnoRep.tmf.bg.ac.rs/handle/123456789/128 AB - Liposome are promising drug carrier systems being developed. Their successful use in the treatment of several diseases demonstrates that a solid rationale for clinical development of liposomes as antimicrobial drug carriers can be established. There are a number of potential drug candidates for liposome encapsulation. The involvement of several biotechnology companies has culminated in the design and licensing of formulations for the treatment of certain microbial infections and cancers. Understanding of liposome behavior in the body and of the physicochemical mechanisms involved in the interaction of liposome, drug, and cellular targets is essential for their future applications. PB - Taylor & Francis Ltd, Abingdon T2 - Drug Development and Industrial Pharmacy T1 - Liposomes as carriers of antimicrobial drugs EP - 488 IS - 5 SP - 483 VL - 23 DO - 10.3109/03639049709148497 ER -
@article{ author = "Šiler-Marinković, Slavica and Mojović, Ljiljana and Davinić, V and Bugarski, Branko", year = "1997", abstract = "Liposome are promising drug carrier systems being developed. Their successful use in the treatment of several diseases demonstrates that a solid rationale for clinical development of liposomes as antimicrobial drug carriers can be established. There are a number of potential drug candidates for liposome encapsulation. The involvement of several biotechnology companies has culminated in the design and licensing of formulations for the treatment of certain microbial infections and cancers. Understanding of liposome behavior in the body and of the physicochemical mechanisms involved in the interaction of liposome, drug, and cellular targets is essential for their future applications.", publisher = "Taylor & Francis Ltd, Abingdon", journal = "Drug Development and Industrial Pharmacy", title = "Liposomes as carriers of antimicrobial drugs", pages = "488-483", number = "5", volume = "23", doi = "10.3109/03639049709148497" }
Šiler-Marinković, S., Mojović, L., Davinić, V.,& Bugarski, B.. (1997). Liposomes as carriers of antimicrobial drugs. in Drug Development and Industrial Pharmacy Taylor & Francis Ltd, Abingdon., 23(5), 483-488. https://doi.org/10.3109/03639049709148497
Šiler-Marinković S, Mojović L, Davinić V, Bugarski B. Liposomes as carriers of antimicrobial drugs. in Drug Development and Industrial Pharmacy. 1997;23(5):483-488. doi:10.3109/03639049709148497 .
Šiler-Marinković, Slavica, Mojović, Ljiljana, Davinić, V, Bugarski, Branko, "Liposomes as carriers of antimicrobial drugs" in Drug Development and Industrial Pharmacy, 23, no. 5 (1997):483-488, https://doi.org/10.3109/03639049709148497 . .